Diabetes
Conditions
Keywords
Diabetes Prevention, CVD Risk Reduction, Lifestyle Intervention
Brief summary
Heart disease is a leading cause of death in people in the United States. It is a major problem for those with diabetes. Conditions called the metabolic syndrome and pre-diabetes increase risk for diabetes and heart disease. The metabolic syndrome is a group of disorders that occur at the same time. Overall, one in four American adults has the metabolic syndrome. It is more common in people over the age of 40. The metabolic syndrome includes: 1) large waist size, 2) high triglycerides, 3) low HDL cholesterol, 4) high blood pressure and 5) high fasting blood sugar. People with the metabolic syndrome have at least three of these five risk factors. Pre-diabetes is considered to be present in those with high fasting blood sugar levels below the diabetes range. Research has shown that type 2 diabetes and the metabolic syndrome may be prevented or delayed by making lifestyle changes. It is not known what will most help people continue these healthy changes over time. The purpose of this study is to look at ways to help people continue the healthy lifestyle changes they have made while taking part in a diabetes prevention program called Group Lifestyle Balance (GLB).
Detailed description
Objective: To determine the effectiveness of the Group Lifestyle Balance (GLB) program with an added maintenance component focusing on carbohydrate reduction and hunger management when compared to the GLB program with traditional maintenance. Research Design and Methods: The original Diabetes Prevention Program intervention was modified from a 16 session individual intervention to a 12 session group-based program called Group Lifestyle Balance (GLB). The Diabetes Prevention Support Center (DPSC) has been created to oversee the implementation of diabetes prevention and CVD risk reduction in various community settings. GLB is a 12-session group based program that focuses on a low fat diet, weight loss and physical activity. This evidence-based intervention is directed at those with pre-diabetes and/or the metabolic syndrome. A monthly maintenance component will be added which provides support in assisting individuals who have completed the 12-session course in the maintenance of healthy lifestyle changes. The efficacy (in terms of weight reduction) of an added maintenance component focusing on carbohydrate reduction and hunger management will be compared to traditional maintenance. Participants will be randomly assigned to either GLB traditional maintenance (GLB-TM) or GLB and carbohydrate reduced maintenance (GLB-CRM). There will be two groups of approximately 15 subjects in each intervention assignment, for a total of approximately 30 subjects per intervention group and approximately 60 subjects taking part overall. Efficacy in both groups will be assessed by pre and post-intervention measures of diet (weight loss) and physical activity (the keystones of the intervention), as well as the achievement of the two goals: a 7% weight loss by the end of 6 months and 150 minutes of physical activity per week. Secondary outcomes to be evaluated include the reduction of global CVD risk, as assessed by the Framingham Score, the presence of metabolic syndrome (NCEP ATP III), and a fall in blood sugar. Repeat measures will be obtained at six months and one year for further evaluation and comparison.
Interventions
After completion of the GLB 12 core sessions, participants will be randomly assigned to either Group Lifestyle Balance (GLB) program traditional maintenance or GLB Carb-focused maintenance. Participants will attend monthly maintenance sessions to assist them in maintaining the healthy lifestyle they have adopted during the 12 Core sessions. In addition, they will receive information on healthy carbohydrate intake and hunger management.
After completion of the GLB 12 core sessions, participants will be randomly assigned to either Group Lifestyle Balance (GLB) program traditional maintenance or GLB Carb-focused maintenance. GLB-CF participants will attend monthly maintenance sessions to assist them in maintaining the healthy lifestyle they have adopted during the 12 Core sessions. In addition, they will receive information on healthy carbohydrate intake and hunger management.
Sponsors
Study design
Eligibility
Inclusion criteria
Non-diabetic patients with metabolic syndrome AND/OR pre-diabetes are eligible for this project based on the following criteria: 1. Metabolic Syndrome: Patients with BMI ≥ 25 kg/m2, with at least 3 of the following risk factors for metabolic syndrome: * Waist circumference (\>40 inches men, \>35 inches women) * Blood pressure ≥130 mmHg (systolic) or ≥85 mmHg (diastolic) OR history of diagnosed hypertension * Low HDL level (\<40mg/dL men, \<50 mg/dL women) * Elevated triglyceride level ≥150 mg/dL * Fasting glucose ≥100mg/dL and \<126mg/dL 2. Pre-diabetes: Patients with a BMI ≥25 kg/m2 and pre-diabetes (fasting glucose ≥100 mg/dL and \<126mg/dL) All measures should have been taken within one year of enrollment into the study. A permission for physical activity form must be signed by the participant's physician in order to take part in the study.
Exclusion criteria
* Previous diabetes or diabetes diagnosed as a result of the screening * Age \<18 years old * Women who are currently (or within past 6-weeks) pregnant or lactating * Any patient deemed by their physician not to be a candidate * Any patient planning to leave the area before the end of the GILS * Any patient who is unable to provide informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Weight | Measured at 8 months post intervention and 4 months post-randomization to maintenance group | Weight was measured twice without shoes with the average computed; participants were asked to remove their shoes at each measure. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Diastolic Blood Pressure | Measured at 8 months post intervention and 4 months post-randomization to maintenance group | Blood pressure was measured in a sitting position in the right arm after resting for five minutes. First appearance and last heard (phase V) Korotkoff's sounds were used to define the pressure readings; the measures were repeated twice with a thirty second wait between each reading. |
| Change in Total Cholesterol | Measured at 8 months post intervention and 4 months post-randomization to maintenance group | Total cholesterol was measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant. |
| Change in HDL Cholesterol | Measured at 8 months post intervention and 4 months post-randomization to maintenance group | High-density lipoprotein (HDL) cholesterol was measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant. |
| Change in LDL Cholesterol | Measured at 8 months post intervention and 4 months post-randomization to maintenance group | Low-density lipoprotein (LDL) cholesterol was measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant. |
| Change in Systolic Blood Pressure | Measured at 8 months post intervention and 4 months post-randomization to maintenance group | Blood pressure was measured in a sitting position in the right arm after resting for five minutes. First appearance and last heard (phase V) Korotkoff's sounds were used to define the pressure readings; the measures were repeated twice with a thirty second wait between each reading. |
| Change in Fasting Glucose | Measured at 8 months post intervention and 4 months post-randomization to maintenance group | Fasting plasma glucose was measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant. |
| Change in Glycosylated Hemoglobin A1c (HbA1c) | Measured at 8 months post intervention and 4 months post-randomization to maintenance group | Collected via venous blood draw, the HbA1c level reflects glucose concentration over the previous period (approximately 8-12 weeks, depending on the individual) and provides an indication of long-term glycemic control. |
| Change in Waist Circumference | Measured at 8 months post intervention and 4 months post-randomization to maintenance group | Waist circumference was measured at the midpoint between the lower rib margin and the iliac crest; the measurement was repeated twice and the average computed. |
| Change in Triglycerides | Measured at 8 months post intervention and 4 months post-randomization to maintenance group | Triglycerides were measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant. |
Countries
United States
Participant flow
Recruitment details
The project was implemented in two settings: the first within an urban University campus and the second at a suburban YMCA. Recruitment commenced in May 2009 and was completed in July 2009.
Participants by arm
| Arm | Count |
|---|---|
| GLB Traditional Maintenance (TM) Group Lifestyle Balance (GLB) program Traditional Maintenance. Participants will attend monthly maintenance sessions to assist them in maintaining the healthy lifestyle they have adopted during the 12 Core sessions.
GLB Traditional Maintenance: Group Lifestyle Balance (GLB)-Carb-focused Maintenance: Participants will attend monthly maintenance sessions to assist them in maintaining the healthy lifestyle they have adopted during the 12 Core sessions. In addition, they will receive information on healthy carbohydrate intake and hunger management. | 31 |
| GLB-Carb-focused Maintenance (CF) After completion of the GLB 12 core sessions, participants will be randomly assigned to either Group Lifestyle Balance (GLB) program traditional maintenance or GLB Carb-focused maintenance. GLB-CF participants will attend monthly maintenance sessions to assist them in maintaining the healthy lifestyle they have adopted during the 12 Core sessions. In addition, they will receive information regarding healthy carbohydrate intake and hunger management.
GLB-Carb-focused Maintenance: After completion of the GLB 12 core sessions, participants will be randomly assigned to either Group Lifestyle Balance (GLB) program traditional maintenance or GLB Carb-focused maintenance. GLB-CF participants will attend monthly maintenance sessions to assist them in maintaining the healthy lifestyle they have adopted during the 12 Core sessions. In addition, they will receive information on healthy carbohydrate intake and hunger management. | 29 |
| Total | 60 |
Baseline characteristics
| Characteristic | GLB Traditional Maintenance (TM) | GLB-Carb-focused Maintenance (CF) | Total |
|---|---|---|---|
| Age, Continuous | 55.9 years STANDARD_DEVIATION 9.4 | 53.4 years STANDARD_DEVIATION 11.6 | 54.7 years STANDARD_DEVIATION 10.5 |
| Region of Enrollment United States | 31 participants | 29 participants | 60 participants |
| Sex: Female, Male Female | 20 Participants | 19 Participants | 39 Participants |
| Sex: Female, Male Male | 11 Participants | 10 Participants | 21 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — |
| other Total, other adverse events | 0 / 31 | 0 / 29 |
| serious Total, serious adverse events | 0 / 31 | 0 / 29 |
Outcome results
Change in Weight
Weight was measured twice without shoes with the average computed; participants were asked to remove their shoes at each measure.
Time frame: Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Population: Intention to treat analyses were performed; for those with missing weights at the post-intervention, 8 and 12 month visits, the last documented observation was carried forward. This information was available from the session data, where weight was collected weekly.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| GLB Traditional Maintenance (TM) | Change in Weight | 2.1 pounds | Standard Deviation 5.9 |
| GLB-Carb-focused Maintenance (CF) | Change in Weight | 0.2 pounds | Standard Deviation 7.1 |
Change in Diastolic Blood Pressure
Blood pressure was measured in a sitting position in the right arm after resting for five minutes. First appearance and last heard (phase V) Korotkoff's sounds were used to define the pressure readings; the measures were repeated twice with a thirty second wait between each reading.
Time frame: Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Population: Participants with relevant medication changes were excluded.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| GLB Traditional Maintenance (TM) | Change in Diastolic Blood Pressure | -2.1 mmHg | Standard Deviation 7 |
| GLB-Carb-focused Maintenance (CF) | Change in Diastolic Blood Pressure | -3.2 mmHg | Standard Deviation 8.8 |
Change in Fasting Glucose
Fasting plasma glucose was measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant.
Time frame: Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Population: Participants with relevant medication changes were excluded.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| GLB Traditional Maintenance (TM) | Change in Fasting Glucose | 1.2 mg/dl | Standard Deviation 4.7 |
| GLB-Carb-focused Maintenance (CF) | Change in Fasting Glucose | 0.2 mg/dl | Standard Deviation 6.9 |
Change in Glycosylated Hemoglobin A1c (HbA1c)
Collected via venous blood draw, the HbA1c level reflects glucose concentration over the previous period (approximately 8-12 weeks, depending on the individual) and provides an indication of long-term glycemic control.
Time frame: Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Population: Participants with relevant medication changes were excluded.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| GLB Traditional Maintenance (TM) | Change in Glycosylated Hemoglobin A1c (HbA1c) | -0.06 percentage of glycosylated hemoglobin | Standard Deviation 0.18 |
| GLB-Carb-focused Maintenance (CF) | Change in Glycosylated Hemoglobin A1c (HbA1c) | -0.08 percentage of glycosylated hemoglobin | Standard Deviation 0.18 |
Change in HDL Cholesterol
High-density lipoprotein (HDL) cholesterol was measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant.
Time frame: Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Population: Participants with medication changes relevant to the outcome were excluded.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| GLB Traditional Maintenance (TM) | Change in HDL Cholesterol | 2.9 mg/dl | Standard Deviation 7 |
| GLB-Carb-focused Maintenance (CF) | Change in HDL Cholesterol | 5.1 mg/dl | Standard Deviation 6.4 |
Change in LDL Cholesterol
Low-density lipoprotein (LDL) cholesterol was measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant.
Time frame: Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Population: Participants with medication changes relevant to the outcome were excluded.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| GLB Traditional Maintenance (TM) | Change in LDL Cholesterol | 5.2 mg/dl | Standard Deviation 20 |
| GLB-Carb-focused Maintenance (CF) | Change in LDL Cholesterol | 5.8 mg/dl | Standard Deviation 23.3 |
Change in Systolic Blood Pressure
Blood pressure was measured in a sitting position in the right arm after resting for five minutes. First appearance and last heard (phase V) Korotkoff's sounds were used to define the pressure readings; the measures were repeated twice with a thirty second wait between each reading.
Time frame: Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Population: Participants with relevant medication changes were excluded.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| GLB Traditional Maintenance (TM) | Change in Systolic Blood Pressure | -0.43 mmHg | Standard Deviation 10.5 |
| GLB-Carb-focused Maintenance (CF) | Change in Systolic Blood Pressure | -3.6 mmHg | Standard Deviation 10.8 |
Change in Total Cholesterol
Total cholesterol was measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant.
Time frame: Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Population: Participants with medication changes relevant to the outcome were excluded.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| GLB Traditional Maintenance (TM) | Change in Total Cholesterol | 8.6 mg/dl | Standard Deviation 23.2 |
| GLB-Carb-focused Maintenance (CF) | Change in Total Cholesterol | 15.4 mg/dl | Standard Deviation 23.7 |
Change in Triglycerides
Triglycerides were measured after at least an eight-hour fast using the Cholestech LDX System by a certified research assistant.
Time frame: Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Population: Participants with relevant medication changes were excluded.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| GLB Traditional Maintenance (TM) | Change in Triglycerides | -0.003 mg/dl | Standard Deviation 0.22 |
| GLB-Carb-focused Maintenance (CF) | Change in Triglycerides | -0.006 mg/dl | Standard Deviation 39 |
Change in Waist Circumference
Waist circumference was measured at the midpoint between the lower rib margin and the iliac crest; the measurement was repeated twice and the average computed.
Time frame: Measured at 8 months post intervention and 4 months post-randomization to maintenance group
Population: Participants with relevant medication changes were excluded.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| GLB Traditional Maintenance (TM) | Change in Waist Circumference | -0.4 inches | Standard Deviation 1.3 |
| GLB-Carb-focused Maintenance (CF) | Change in Waist Circumference | -0.2 inches | Standard Deviation 1.4 |